Skip to main content

EPRX · Eupraxia Pharmaceuticals Inc. · Documents

9.2300 CAD -0.2500 (-2.64%) At close · Nov 5 Intraday price with Plus

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

2024
Mar 12
Offering documents SEDAR+
4 offering documents
  • Consent letter of underwriters' legal counsel 1
  • Securities offerings 1
  • Underwriting or agency agreements (or amendment thereto) 1
  • Consent letter of issuer's legal counsel 1
Feb 15 to Feb 5
Offering documents SEDAR+
9 offering documents
  • Other undertakings 1
  • Final short form prospectus 1
  • Consent letter of issuer's legal counsel 1
  • Securities offerings 1
  • Other offering documents 5
Jan 18 to Jan 8
Offering documents SEDAR+
5 offering documents
  • Amendment to (or amended) preliminary short form prospectus 1
  • Decision Document (Amendment to Preliminary) 1
  • Decision Document (Preliminary) 1
  • Qualification certificate 1
  • Other offering documents 1
2023
Nov 14
Report SEDAR+
MD&A
Aug 28
Offering documents SEDAR+
1 offering document
  • Report of exempt distribution excluding Schedule 1 of 45-106F1 1
Aug 11
Report SEDAR+
MD&A
Jun 22 to Jun 15
Offering documents SEDAR+
9 offering documents
  • Auditors' consent letter 1
  • Final short form prospectus 1
  • Consent letter of issuer's legal counsel 1
  • Non-issuer's submission to jurisdiction and appointment of agent 1
  • Other offering documents 5
Showing 251–300 of 414 documents